Andrew Mamalis1, Jared Jagdeo. 1. *Department of Dermatology, University of California at Davis, Sacramento, California; †Dermatology Service, Sacramento VA Medical Center, Mather, California; ‡Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York.
Abstract
BACKGROUND: Red light is part of the visible light spectrum that does not generate DNA adducts associated with skin cancer and photoaging and may represent a safer therapeutic modality for treatment of keloid scars and other fibrotic skin diseases. Our laboratory previously demonstrated that light-emitting diode-generated red light (LED-RL) inhibits proliferation of skin fibroblasts. The effects of LED-RL on keloidal skin are not well characterized. OBJECTIVE: To determine the effect of LED-RL on keloid-derived fibroblast proliferation and viability in vitro. METHODS: Irradiation of primary keloid-derived human skin fibroblasts using LED-RL panels was performed in vitro, and modulation of proliferation and viability was quantified using trypan blue dye exclusion assay. Statistical analysis was performed using analysis of variance to compare treatment arms and the Student t-test to compare each treatment arm with the paired bench control arm. RESULTS: Keloid fibroblasts treated with LED-RL 240, 320, and 480 J/cm demonstrated statistically significant dose-dependent decreases in relative proliferation rate of 12.4%, 16.5%, and 28.9%, respectively, compared with matched nonirradiated controls (p < .05) and did not significantly alter viability relative to the matched nonirradiated controls. CONCLUSION: Light-emitting diode-generated red light can inhibit keloid fibroblast proliferation in a dose-dependent manner without altering viability. Light-emitting diode-generated red light has the potential to contribute to the treatment of keloids and other fibrotic skin diseases and is worthy of further translational and clinical investigation.
BACKGROUND: Red light is part of the visible light spectrum that does not generate DNA adducts associated with skin cancer and photoaging and may represent a safer therapeutic modality for treatment of keloid scars and other fibrotic skin diseases. Our laboratory previously demonstrated that light-emitting diode-generated red light (LED-RL) inhibits proliferation of skin fibroblasts. The effects of LED-RL on keloidal skin are not well characterized. OBJECTIVE: To determine the effect of LED-RL on keloid-derived fibroblast proliferation and viability in vitro. METHODS: Irradiation of primary keloid-derived human skin fibroblasts using LED-RL panels was performed in vitro, and modulation of proliferation and viability was quantified using trypan blue dye exclusion assay. Statistical analysis was performed using analysis of variance to compare treatment arms and the Student t-test to compare each treatment arm with the paired bench control arm. RESULTS: Keloid fibroblasts treated with LED-RL 240, 320, and 480 J/cm demonstrated statistically significant dose-dependent decreases in relative proliferation rate of 12.4%, 16.5%, and 28.9%, respectively, compared with matched nonirradiated controls (p < .05) and did not significantly alter viability relative to the matched nonirradiated controls. CONCLUSION: Light-emitting diode-generated red light can inhibit keloid fibroblast proliferation in a dose-dependent manner without altering viability. Light-emitting diode-generated red light has the potential to contribute to the treatment of keloids and other fibrotic skin diseases and is worthy of further translational and clinical investigation.
Authors: Robson Alexandre Brochetti; Mayara Peres Leal; Raíssa Rodrigues; Renata Kelly da Palma; Luis Vicente Franco de Oliveira; Anna Carolina Ratto Tempestini Horliana; Amílcar Sabino Damazo; Ana Paula Ligeiro de Oliveira; Rodolfo Paula Vieira; Adriana Lino-Dos-Santos-Franco Journal: Lasers Med Sci Date: 2017-07-16 Impact factor: 3.161
Authors: Yan Wu; Tingting Zhu; Yaoyao Yang; Hong Gao; Chunxia Shu; Qiang Chen; Juan Yang; Xiang Luo; Yao Wang Journal: Lasers Med Sci Date: 2021-03-15 Impact factor: 3.161
Authors: Alana Kurtti; Julie K Nguyen; Jeremy Weedon; Andrew Mamalis; Yi Lai; Natasha Masub; Amaris Geisler; Daniel M Siegel; Jared R Jagdeo Journal: J Biophotonics Date: 2021-05-04 Impact factor: 3.207
Authors: Evan Austin; Alisen Huang; Jennifer Y Wang; Marc Cohen; Edward Heilman; Emanual Maverakis; Josef Michl; Jared Jagdeo Journal: Front Oncol Date: 2022-06-24 Impact factor: 5.738